Browsing by Author Borovcanin, Milica

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
PreviewIssue DateTitleAuthor(s)
PaperMissing.pdf.jpg1-Jun-2013Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory responseBorovcanin, Milica; Jovanovic I.; Radosavljevic, Gordana; Djukić Dejanović S.; Stefanovic V.; Arsenijevic, Nebojsa; Lukic, Miodrag
10.1515-SJECR-2015-0047.pdf.jpg1-Mar-2016Cannabis as a possible treatment for spasticity in multiple sclerosisVesić, Katarina; Dejanovic S.; Borovcanin, Milica; Samardzic J.; Toncev, Gordana
10.3389-fpsyt.2020.612347.pdf.jpg23-Dec-2020Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 TreatmentMuric, Nemanja; Arsenijevic, Nebojsa; Borovcanin, Milica
PaperMissing.pdf.jpg1-Nov-2012Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapseBorovcanin, Milica; Jovanovic I.; Radosavljevic, Gordana; Djukić Dejanović S.; Banković D.; Arsenijevic, Nebojsa; Lukic, Miodrag
10.2298-VSP150616106S.pdf.jpg1-Apr-2017In vivo methodology in behavioural pharmacology - where are we now?Samardzic J.; Borovcanin, Milica; Dejanovic S.; Jancić J.; Djuric M.; Obradović D.
PaperMissing.pdf.jpg1-Jan-2015Increase systemic levels of IL-23 as a possible constitutive marker in schizophreniaBorovcanin, Milica; Jovanovic I.; Dejanovic S.; Radosavljevic, Gordana; Arsenijevic, Nebojsa; Lukic, Miodrag
10.3389-fpsyt.2017.00221.pdf.jpg6-Nov-2017Interleukin-6 in schizophrenia-Is there a therapeutic relevance?Borovcanin, Milica; Jovanovic I.; Radosavljevic, Gordana; Pantic, Jelena; Janićijević M.; Arsenijevic, Nebojsa; Lukic, Miodrag
10.1515-sjecr-2017-0031.pdf.jpg10-Feb-2018Interplay of Brain-Derived Neurotrophic Factor and Cytokines in SchizophreniaJanicijevic A.; Dejanovic S.; Borovcanin, Milica
10.24869-psyd.2017.459.pdf.jpg1-Jan-2017Positive impact of prescribed physical activity on symptoms of schizophrenia: Randomized clinical trialCurcic D.; Stojmenović T.; Djukić Dejanović S.; Dikić N.; Vesic-Vukasinovic M.; Radivojevic N.; Andjelkovic M.; Borovcanin, Milica; Djokic, Gorica
PaperMissing.pdf.jpg1-Mar-2016Possible role of TGF-B pathways in schizophreniaBorovcanin, Milica; Jovanovic I.; Dejanovic S.; Radosavljevic, Gordana; Arsenijevic, Nebojsa; Lukic, Miodrag
10.1515-SJECR-2016-0077.pdf.jpg1-Sep-2017Quality of life in primary insomnia: Three-week treatment with zolpidem vs. lorazepamJanjić V.; Radmanovic, Branimir; Bukumirič Z.; Dejanovic S.; Muric, Nemanja; Borovcanin, Milica
PaperMissing.pdf.jpg1-Dec-2015The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophreniaStefanovic V.; Mihajlovic, Goran; Nenadović M.; Dejanovic S.; Borovcanin, Milica; Trajkovič G.
10.2298-VSP170814129B.pdf.jpg1-Jan-2019The use of complementary serological and molecular testing for blood-borne pathogens and evaluation of socio-demographic characteristics of intravenous drug users on substitution therapy from Šumadia district of SerbiaBorovcanin N.; Ristanović E.; Todorovic, Milos; Borovcanin, Milica; Jovanovic, Mirjana; Balint B.